Semenov Lab

Clinical Informatics and AI for Healthcare

The Semenov lab at the Massachusetts General Hospital leverages advanced machine learning and multi-modal data fusion approaches to enable precision medicine at the interface or dermatology, oncology, and computational biology. Our lab aims to develop personalized approaches to cancer prognostication, treatment response, and treatment toxicity development leveraging a wide range of data sources, including digital pathology, multiplex imaging, genomics, spatial transcriptomics, population-level registries, and high-throughput electronic health record data.

We are affiliated with Harvard Data Science Initiative, Department of Biomedical Informatics, Broad Institute, and Dana Farber/Harvard Cancer Center.

Contacts:

Email: ysemenov<at>mgh.harvard.edu

Location: 399 Revolution Drive, Suite 1120, Somerville, MA 02145

Administrative Assistant:

Laurie Frank: lfrank2<at>mgh.harvard.edu

DR. YEVGENIY (“EUGENE”) R. SEMENOV

Yevgeniy (“Eugene”) R. Semenov, MD, MA is a board-certified dermatologist and co-Director of the Oncodermatology Program at Mass General Hospital, and Assistant Professor in Dermatology at Harvard Medical School. He has extensive expertise and training in clinical informatics, health economics, and decision analytics. Dr. Semenov’s research focuses on developing precision medicine tools in dermatology and cutaneous oncology, with a particular interest in prognosticating immunotherapy response and toxicity development, particularly in early-stage melanoma.